http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2305520-T3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf32b60391b469c41e86c353437f5751 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 |
| filingDate | 2003-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2008-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_34aef6fafe38af99f77015f3b9d78e79 |
| publicationDate | 2008-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2305520-T3 |
| titleOfInvention | IMIDAZO DERIVATIVES (1,5A) PIRIDINE AND METHODS TO TREAT DISEASES MEDIATED BY ALDOSTERONE. |
| abstract | A compound of the formula (I) (See formula) in which R 1 is an aryl radical of the formula (See formula) in which R 4 is cycloalkyl, aryl or heterocyclyl; or R4 is optionally substituted alkyl, alkoxy, hydroxy, halogen or trifluoromethyl, provided that neither R5 nor R6 are hydrogen; R5 is hydrogen, halogen, cyano, alkoxy or trifluoromethyl; or R4 and R5 combined together with the carbon atoms to which they are attached form an optionally substituted 5 or 6-membered aromatic or heteroaromatic ring, provided that R4 and R5 are linked to carbon atoms adjacent to each other; or R4 and R5 combined are alkylene which, taken together with the carbon atoms to which they are attached, forms a 4- to 7-membered ring, provided that R4 and R5 are linked to carbon atoms adjacent to each other; R6 is hydrogen, halogen, cyano, nitro, trifluoromethyl, optionally substituted lower alkyl, optionally substituted amino, alkoxy, carboxy, alkoxycarbonyl, sulfonyl or carbamoyl; R2 and R3 are, independently, hydrogen, trifluoromethyl or alkoxy; or R2 and R3 combined together with the carbon atoms to which they are attached form an optionally substituted 5- or 6-membered aromatic or heteroaromatic ring; or R2 and R3 combined are alkylene which, taken together with the carbon atoms to which they are attached, forms a 4- to 7-membered ring; or a pharmaceutically acceptable salt thereof. |
| priorityDate | 2002-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 300.